1. Home
  2. About Us
  3. Where We Are
  4. Manufacturing Pharma

Manufacturing Pharma

At our pharmaceutical production facility, we oversee the entire process—from research and sourcing to manufacturing and packaging—delivering high-quality essential medicines to our patients

Where Precision meets Performance

At our L’Aquila site, we produce the main pharmaceutical forms for our flagship products: Oki, Oki Task, Fluifort, and Levotuss. Our production lines boast exceptional capacity, reaching approximately 70,000 packages per shift. This production speed has steadily increased over time. While machinery plays a key role, the true credit goes to our people. Their unwavering dedication to performance and their commitment—both technical and cultural—make continuous improvement possible.

 

Our pharmaceutical manufacturing is divided into:

  • Solid formulations (granulated and orodispersible products)
  • Liquid formulations, in both small and large volumes (syrups, mouthwashes, drops, and sprays)

 

The entire supply chain is managed in-house, from Research & Development to final packaging.

A 1,380 kW trigeneration system enables the self-production of approximately 70% of the annual electricity consumption, amounting to around 15 MWh of energy generated internally.

An efficiency improvement plan is currently underway to reduce energy consumption related to the production and distribution of compressed air, including the adoption of new technologies to replace outdated systems and a targeted program for leak detection and repair.

Water consumption, both for industrial processes and civil use, is continuously monitored and optimized.

In line with the philosophy of continuous improvement, the facility implements waste separation plans to enhance environmental sustainability.

Oral Solid Dosage Production

Solid formulations include granulated products, including orodispersible forms. Our production area features a warehouse with a capacity of approximately 5,000 pallet spaces and three weighing zones, allowing us to handle 1,433 US tonnes of powders.

After weighing the raw materials, the active ingredient and excipients are processed into granules. Some products require the granules to be coated with multiple layers of excipients.

Our facility is equipped with three granulators, one of which is the largest in Europe. It spans three floors and can process 2,866 lb per batch, enabling us to granulate around 1,653 US tonnes of pharmaceutical powders annually.

Once the product formulation is complete, it is packaged in sachets or stick packs, depending on specific requirements. The production site includes five packaging lines dedicated to granulated products.

Liquid Formulations

Liquid formulations include syrups, mouthwashes, drops, and sprays. Two distinct packaging lines are available: one for small-volume products and one for large-volume products.

After weighing the raw materials, the production process begins with the preparation of the product inside a controlled-condition tank. Here, the active ingredient is mixed with pharmaceutical-grade water, sugar, and excipients, then heated and stirred. Syrups are stored in tanks with a capacity of approximately 5,283 gallons.

Once ready, the medicine is packaged in glass or plastic containers, then boxed, wrapped, and palletized through a fully automated procedure.

  • 5,000 pallet spaces in a temperature- and humidity-controlled pharmaceutical warehouse
  • 1,433 US tonnes

Quality is at the heart of everything we do. At every stage of the product lifecycle, we adopt the highest international standards to ensure safety, efficacy, and regulatory compliance, relying on teamwork that spans all company functions involved in production and logistics. 

We operate in accordance with Good Manufacturing Practices (GMP) guidelines and continuously invest in technological innovation, staff training, and ongoing process improvement. Both production units at our facility undergo rigorous internal controls and regular inspections by competent authorities. 

Our facilities are authorized to produce pharmaceuticals and biotech active ingredients, and are regularly inspected by national and international health authorities, including:

AIFA

(Italian Medicines Agency) – Primary and Biotech

FDA

(Food and Drug Administration, USA) – Biotech

Roszdravnadzor

(Federal Service for Surveillance in Healthcare, Russia) – Primary

We use advanced digital systems for document management and real-time monitoring of production processes, ensuring data integrity, transparency, traceability, and rapid response.

We collaborate with qualified suppliers and trusted partners to build a robust, sustainable, and fully integrated supply chain aligned with our quality standards.

Our commitment is always aimed at exceeding the expectations of patients and healthcare professionals, delivering pharmaceutical products that meet the highest quality requirements.